Jazz Pharmaceuticals plc (JAZZ) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 408.2M | 362.52M | 474.62M | 88.86M | 429.78M | 398.58M | 398.75M | 331.35M | 267.23M | 167.34M | 307.19M | 296.76M |
| Operating CF Margin % | 38.19% | 30.26% | 42.15% | 8.5% | 47.87% | 36.63% | 37.8% | 32.36% | 29.63% | 16.54% | 31.6% | 31% |
| Operating CF Growth % | -5.02% | -9.05% | 19.03% | -73.18% | 60.83% | 138.19% | 29.8% | 11.65% | -16.68% | -51.07% | -26.51% | -2.07% |
| Net Income | 293.1M | -903.55M | 251.41M | -718.47M | -92.54M | 191.12M | 215.06M | 168.57M | -14.62M | 94.15M | 146.82M | 104.44M |
| Depreciation & Amortization | 181.4M | 503.75M | 178.25M | 174.01M | 164.87M | 168.42M | 165.23M | 163.03M | 163.38M | 159.2M | 162.56M | 159.58M |
| Stock-Based Compensation | 74.5M | 199.81M | 88.13M | 64.5M | 67.65M | 70.19M | 59.76M | 56.65M | 61.44M | 52.94M | 56.12M | 61.43M |
| Deferred Taxes | -66.2M | -154.09M | -271.41M | -66.42M | -43.83M | -2.35M | -64.4M | -75.18M | -66.39M | -35.9M | -78.92M | -79.33M |
| Other Non-Cash Items | -74.6M | 789.33M | 97.39M | 962.35M | 45.73M | 51.15M | 49.49M | 45.08M | 67.01M | 77.95M | 45.17M | 67.86M |
| Working Capital Changes | 0 | -72.74M | 130.85M | -327.12M | 287.9M | -79.93M | -26.38M | -26.81M | 56.4M | -181.01M | -24.55M | -17.21M |
| Change in Receivables | 14.2M | -65.81M | -51M | -55.52M | 66.05M | 864K | -22.26M | 8.72M | -8.44M | -75.46M | -18.86M | 13.98M |
| Change in Inventory | 37.5M | 7.72M | -31.91M | -26.23M | -35.62M | -18.66M | -9.29M | -4.75M | -12.84M | -1.4M | -4.93M | -816K |
| Change in Payables | -21.4M | -28.97M | 62.36M | -12.67M | 19.13M | -3.13M | -12.79M | 15.45M | -19.6M | -8.1M | 10.24M | -26.82M |
| Cash from Investing | 123.1M | -372.16M | -327.8M | -641.02M | -168.93M | -193.29M | 214.09M | -257.09M | -271.9M | 101.8M | -174.3M | -85.74M |
| Capital Expenditures | -19.7M | -40.73M | -45.17M | -12.97M | -13.88M | -13.29M | -10.79M | -7.09M | -6.9M | -10.1M | -4.3M | -5.74M |
| CapEx % of Revenue | 1.84% | 3.4% | 4.01% | 1.24% | 1.55% | 1.22% | 1.02% | 0.69% | 0.77% | 1% | 0.44% | 0.6% |
| Acquisitions | 0 | -858.05M | 0 | -858.05M | 0 | 0 | 0 | 0 | 0 | 0 | -20M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -377.2M | -123.33M | -42.5M | -680.05M | -25M | 0 | 0 | 0 | -10M | -18M | 20M | 0 |
| Cash from Financing | -78.5M | 75.44M | -10.83M | -124.53M | -813.47M | -8.28M | 246.43M | -161.09M | -56.55M | -100.31M | -78.49M | -96.67M |
| Debt Issued (Net) | 0 | -7.75M | -7.75M | -7.75M | -757.75M | -13.47M | 398.02M | -7.75M | -7.75M | -7.75M | -7.75M | -7.75M |
| Equity Issued (Net) | 0 | 85.19M | 733K | -114.53M | 0 | 9.2M | -150M | -150.49M | 494K | -99.8M | -74.37M | -84.73M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -125.02M | 0 | 0 | -150M | -161.43M | 0 | -99.8M | -74.37M | -95.59M |
| Other Financing | -78.5M | -2M | -3.81M | -2.25M | -55.72M | -4M | -1.59M | -2.85M | -49.3M | 7.24M | 3.63M | -4.19M |
| Net Change in Cash | 452.4M | 75.83M | 46.19M | -672.07M | -550.92M | 234.73M | 862.33M | 62.42M | 27.07M | 170.62M | 53.39M | -5.61M |
| Free Cash Flow | 388.5M | 296.79M | 459.44M | 100.89M | 390.9M | 385.29M | 387.96M | 324.26M | 260.32M | 139.24M | 302.9M | 291.03M |
| FCF Margin % | 36.35% | 24.78% | 40.8% | 9.65% | 43.54% | 35.41% | 36.77% | 31.67% | 28.86% | 13.76% | 31.16% | 30.4% |
| FCF Growth % | -0.61% | -22.97% | 18.43% | -68.89% | 50.16% | 176.72% | 28.08% | 11.42% | -17.85% | -58.14% | -28.38% | 0.09% |
| FCF per Share | 5.88 | 4.87 | 7.46 | 1.65 | 6.41 | 6.26 | 6.14 | 4.66 | 4.16 | 2.00 | 4.25 | 3.96 |
| FCF Conversion (FCF/Net Income) | 1.39x | 1.78x | 1.89x | -0.12x | -4.64x | 2.09x | 1.85x | 1.97x | -18.28x | 1.78x | 2.09x | 2.84x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |